<?xml version="1.0" encoding="UTF-8"?>
<p>The number of new human immunodeficiency virus (HIV) diagnoses in Belgium is falling, with a decrease of 2% in 2017 compared to 2016 and 27.5% compared to 2012. There is wide access to testing and care [
 <xref rid="B1-viruses-11-01096" ref-type="bibr">1</xref>] and since December 2016, the immediate initiation of antiretroviral therapy after diagnosis is recommended for every patient. In 2017, 16,070 HIV-infected persons were in care and 97% of these were on therapy. Of individuals treated for at least six months, 97% attained a viral load of less than 200 copies/mL [
 <xref rid="B2-viruses-11-01096" ref-type="bibr">2</xref>]. Despite these encouraging numbers, 890 new HIV diagnoses were registered in 2017, corresponding to a rate of 7.9 infections per 100,000 individuals, which is well above the average rate in the European Union (6.9 to 6.2 per 100,000) [
 <xref rid="B3-viruses-11-01096" ref-type="bibr">3</xref>]. Nearly half (49%) of all new diagnoses are established in men having sex with men (MSM), mainly of Belgian or European origin, whereas for infections through heterosexual contacts, representing 48% of all new diagnoses, 49% were diagnosed in Sub-Saharan Africans [
 <xref rid="B2-viruses-11-01096" ref-type="bibr">2</xref>].
</p>
